Zaburzenia kognitywne u osób z epilepsją w Peru

Preprint (medRxiv/bioRxiv)➕ 01.09.2026Preprint (medRxiv/bioRxiv)

Cognitive Impairment Among People with Epilepsy in Peru

W skrócie

[Preprint - wstępne wyniki] Badanie wykazało, że zaburzenia pamięci i uwagi są powszechne u chorych na epilepsję w Peru - dotyczy około 1 na 6 pacjentów. Naukowcy zbadali ponad 760 osób i odkryli, że starszy wiek i niższy poziom edukacji są związane z gorszym funkcjonowaniem poznawczym. Wyniki podkreślają potrzebę oceny i wsparcia dla zaburzeń poznawczych jako integralnej części leczenia epilepsji, szczególnie w krajach o ograniczonych zasobach medycznych.

Oryginalny abstract (angielski)

Objective: Cognitive impairment is a common comorbidity among people with epilepsy (PWE) and is associated with disability and reduced quality of life. We characterized the burden of cognitive impairment and identified factors associated with cognitive performance in a large, population-based cohort of PWE living in Northern Peru, a region highly endemic for Taenia solium where neurocysticercosis (NCC) is a common cause of acquired epilepsy. Methods: PWE enrolled in a population-based cohort in Northern Peru between 2007 and 2020 completed the Mini-Mental State Examination (MMSE) at enrollment. Cognitive impairment was defined as an MMSE score Results: Among 764 participants, the mean MMSE score was 26.4 (SD 4.2), and 16.4% met criteria for cognitive impairment. Memory and attention were the most affected domains. In multivariable analysis, older age and lower educational attainment were independently associated with poorer cognitive performance. Conclusion: In this large, community-based cohort from Northern Peru, approximately 1 in 6 PWE had abnormal global cognition on the MMSE, with memory and attention most affected. These findings underscore the importance of incorporating cognitive evaluation and management into comprehensive epilepsy care, particularly in resource-limited settings where cognitive morbidity may be underrecognized. Given the potential for cognitive difficulties to compound disability and adversely affect quality of life, identifying and addressing cognitive morbidity may be especially important in populations already facing substantial barriers to epilepsy care.

Metadane publikacji

Journal
Preprint (medRxiv/bioRxiv)
Data publikacji
31.08.2026
DOI
10.64898/2026.08.28.26361672
Europe PMC ID
PPR1309058
Autorzy
Allen SE, Phillips C, Wardle MT, Moyano LM, Bustos JA, Rojas LL, Reto N, Bolivar LM, O'Neal S, Garcia HH
Źródło
Preprint (medRxiv/bioRxiv)